rosiglitazone has been researched along with Orphan Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hernandez, AV; Ioannidis, JP; Kattan, MW; Walker, E | 1 |
1 review(s) available for rosiglitazone and Orphan Diseases
Article | Year |
---|---|
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.
Topics: Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Incidence; Male; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Rare Diseases; Reproducibility of Results; Risk Assessment; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones | 2008 |